FDA OKs outpatient trial for artificial pancreas

03/23/2012 | Medical News Today

The Artificial Pancreas Project, a collaboration among several universities, received FDA approval to conduct outpatient clinical trials in the U.S. for its hand-held device designed to automatically measure blood glucose levels and provide insulin as needed in type 1 diabetes patients. The trial could begin in about six weeks, one researcher said.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA